Sarepta Therapeutics | SRPT - SCHULD

Aktienkurs
17.55
Täglich Wechseln
-1.13 -6.05%
Monatlich
-17.10%
Jährlich
-51.83%
Q2 Prognose
17.20




SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amgen USD 54.6B 17M 2025-12
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Capricor Therapeutics USD 3.38M 0 2025-03
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Gilead Sciences USD 24.94B 5M 2025-12
Incyte USD 39.43M 982K 2026-03
Insmed USD 727.62M 275K 2026-03
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Moderna USD 1.31B 571M 2025-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 63.73B 231M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 20.33B 1.43B 2025-12
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.99B 44M 2026-03